Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.

Autor: Davisse-Paturet C; Université Paris-Saclay, Inserm, UVSQ, CESP, Paris, France., Orri M; McGill University, Department of Psychiatry, Montreal, Québec, Canada., Legleye S; Université Paris-Saclay, Inserm, UVSQ, CESP, Paris, France.; Ensai, Bruz, France., Florence AM; Sorbonne University, Inserm, Pierre Louis institute of Epidemiology and Public Health, Paris, France., Hazo JB; French Ministry of Solidarity and Health, Drees, Paris, France., Warszawski J; APHP, Paris-Saclay University, Department of Epidemiology and Public Health, Le Kremlin-Bicêtre, France., Falissard B; Université Paris-Saclay, Inserm, UVSQ, CESP, Paris, France., Geoffroy MC; McGill University, Department of Psychiatry, Montreal, Québec, Canada.; McGill University, Department of Educational and Counselling Psychology, Québec, Canada., Melchior M; Sorbonne University, Inserm, Pierre Louis institute of Epidemiology and Public Health, Paris, France., Rouquette A; Université Paris-Saclay, Inserm, UVSQ, CESP, Paris, France.; APHP, Paris-Saclay University, Department of Epidemiology and Public Health, Le Kremlin-Bicêtre, France.
Jazyk: angličtina
Zdroj: PLoS medicine [PLoS Med] 2023 Feb 14; Vol. 20 (2), pp. e1004171. Date of Electronic Publication: 2023 Feb 14 (Print Publication: 2023).
DOI: 10.1371/journal.pmed.1004171
Abstrakt: Background: A higher risk of suicidal ideation associated with self-report of Coronavirus Disease 2019 (COVID-19)-like symptoms or COVID-19 infection has been observed in cross-sectional studies, but evidence from longitudinal studies remains limited. The aims of this study were 2-fold: (1) to explore if self-reported COVID-19-like symptoms in 2020 were associated with suicidal ideation in 2021; (2) to explore if the association also existed when using a biological marker of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in 2020.
Methods and Findings: A total of 52,050 participants from the French EpiCov cohort were included (median follow-up time = 13.7 months). In terms of demographics, 53.84% were women, 60.92% were over 45 years old, 82.01% were born in mainland France from parents born in mainland France, and 59.38% completed high school. COVID-19-like symptoms were defined as participant report of a sudden loss of taste/smell or fever alongside cough, shortness of breath, or chest oppression, between February and November 2020. Symptoms were self-reported at baseline in May 2020 and at the first follow-up in Autumn 2020. Serology-confirmed SARS-CoV-2 infection in 2020 was derived from Spike protein ELISA test screening in dried-blood-spot samples. Samples were collected from October 2020 to March 2021, with 94.4% collected in 2020. Suicidal ideation since December 2020 was self-reported at the second follow-up in Summer 2021. Associations of self-reported COVID-19-like symptoms and serology-confirmed SARS-CoV-2 infection in 2020 with suicidal ideation in 2021 were ascertained using modified Poisson regression models, weighted by inverse probability weights computed from propensity scores. Among the 52,050 participants, 1.68% [1.54% to 1.82%] reported suicidal ideation in 2021, 9.57% [9.24% to 9.90%] had a serology-confirmed SARS-CoV-2 infection in 2020, and 13.23% [12.86% to 13.61%] reported COVID-19-like symptoms in 2020. Self-reported COVID-19-like symptoms in 2020 were associated with higher risks of later suicidal ideation in 2021 (Relative Riskipw [95% CI] = 1.43 [1.20 to 1.69]), while serology-confirmed SARS-CoV-2 infection in 2020 was not (RRipw = 0.89 [0.70 to 1.13]). Limitations of this study include the use of a single question to assess suicidal ideation, the use of self-reported history of mental health disorders, and limited generalizability due to attrition bias.
Conclusions: Self-reported COVID-19-like symptoms in 2020, but not serology-confirmed SARS-CoV-2 infection in 2020, were associated with a higher risk of subsequent suicidal ideation in 2021. The exact role of SARS-CoV-2 infection with respect to suicide risk has yet to be clarified. Including mental health resources in COVID-19-related settings could encourage symptomatic individuals to care for their mental health and limit suicidal ideation to emerge or worsen.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Davisse-Paturet et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje